ES2151465T1 - Dna codificante de receptores galr3 de galanina y usos del mismo. - Google Patents

Dna codificante de receptores galr3 de galanina y usos del mismo.

Info

Publication number
ES2151465T1
ES2151465T1 ES97910850T ES97910850T ES2151465T1 ES 2151465 T1 ES2151465 T1 ES 2151465T1 ES 97910850 T ES97910850 T ES 97910850T ES 97910850 T ES97910850 T ES 97910850T ES 2151465 T1 ES2151465 T1 ES 2151465T1
Authority
ES
Spain
Prior art keywords
galanine
nucleic acid
receiver
mamiferous
codifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES97910850T
Other languages
English (en)
Inventor
Jonathan A Bard
Beth Borowsky
Kelli E Smith
Theresa A Branchek
Christophe P G Gerald
Kenneth A Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lundbeck Research USA Inc
Original Assignee
Synaptic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synaptic Pharmaceutical Corp filed Critical Synaptic Pharmaceutical Corp
Publication of ES2151465T1 publication Critical patent/ES2151465T1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN ACIDO NUCLEICO AISLADO QUE CODIFICA UN RECEPTOR DE GALANINA DE MAMIFERO, UNA PROTEINA AISLADA RECEPTORA DE GALANINA, VECTORES QUE COMPRENDEN UN ACIDO NUCLEICO AISLADO QUE CODIFICA UN RECEPTOR DE GALANINA DE MAMIFERO, CELULAS QUE COMPRENDEN DICHOS VECTORES, ANTICUERPOS DIRIGIDOS CONTRA UN RECEPTOR DE GALANINA DE MAMIFERO, SONDAS DE ACIDO NUCLEICO QUE SIRVEN PARA DETECTAR UN ACIDO NUCLEICO QUE CODIFICA GALANINA DE MAMIFERO, OLIGONUCLEOTIDOS ANTISENSE COMPLEMENTARIOS DE SECUENCIAS UNICAS DE ACIDO NUCLEICO QUE CODIFICAN UN RECEPTOR DE GALANINA DE MAMIFERO, ANIMALES TRANSGENICOS NO HUMANOS QUE EXPRESAN EL ADN QUE CODIFICA UN RECEPTOR DE GALANINA DE MAMIFERO NORMAL O MUTANTE, ASI COMO PROCEDIMIENTOS DE DETERMINACION DE ENLACE DE COMPUESTOS PARA RECEPTORES DE GALANINA DE MAMIFERO.
ES97910850T 1996-10-09 1997-10-09 Dna codificante de receptores galr3 de galanina y usos del mismo. Pending ES2151465T1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72813996A 1996-10-09 1996-10-09
US76796496A 1996-12-17 1996-12-17
US78726197A 1997-01-24 1997-01-24
US08/900,230 US6329197B2 (en) 1996-10-09 1997-07-23 DNA encoding galanin GALR3 receptors and uses thereof

Publications (1)

Publication Number Publication Date
ES2151465T1 true ES2151465T1 (es) 2001-01-01

Family

ID=27505578

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97910850T Pending ES2151465T1 (es) 1996-10-09 1997-10-09 Dna codificante de receptores galr3 de galanina y usos del mismo.

Country Status (8)

Country Link
US (5) US6329197B2 (es)
EP (1) EP0956291A4 (es)
JP (1) JP2002514055A (es)
AU (1) AU741041B2 (es)
CA (1) CA2248222A1 (es)
DE (1) DE956291T1 (es)
ES (1) ES2151465T1 (es)
WO (1) WO1998015570A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329197B2 (en) * 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
US20030119096A1 (en) * 1997-01-24 2003-06-26 Bard Jonathan A. Method of treating an abnormality using a GALR3 receptor antagonist
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6693182B1 (en) * 1997-08-22 2004-02-17 Schering Corporation Mammalian galanin receptors
WO1999031130A1 (en) * 1997-12-17 1999-06-24 Merck & Co., Inc. Galanin receptor galr3 and nucleotides encoding same
US6395877B1 (en) 1998-06-30 2002-05-28 Millennium Pharmaceuticals, Inc. 14273 receptor, a novel G-protein coupled receptor
WO2000000611A2 (en) 1998-06-30 2000-01-06 Millennium Pharmaceuticals, Inc. 14273 receptor, a g-protein coupled receptor
US7534579B2 (en) 1998-06-30 2009-05-19 Millennium Pharmaceuticals, Inc. 14273 receptor, a novel G-protein coupled receptor
US6448005B1 (en) 1998-06-30 2002-09-10 Millennium Pharmaceuticals, Inc. 14723 Receptor, a novel G-protein coupled receptor
US6221613B1 (en) 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
ES2272309T3 (es) 1999-08-03 2007-05-01 Millennium Pharmaceuticals, Inc. 15571, una nueva molecula de tipo gpcr de la familia de tipo secretina y sus usos.
WO2001087930A2 (en) * 2000-05-18 2001-11-22 Bayer Aktiengesellschaft Human galanin receptor-like g protein coupled receptor
CA2672805A1 (en) 2001-01-31 2002-08-08 H. Lundbeck A/S Pyrimidine derivatives
US20040127502A1 (en) * 2001-01-31 2004-07-01 Synaptic Pharmaceutical Corporation Use of GAL3 antagonist for treatment of depression
US7081470B2 (en) * 2001-01-31 2006-07-25 H. Lundbeck A/S Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
JP2005507654A (ja) * 2001-08-27 2005-03-24 トゥラリック インコーポレイテッド 増幅した癌遺伝子およびそれらの癌への関与
WO2004014376A1 (en) * 2002-08-07 2004-02-19 Synaptic Pharmaceutical Corporation Gal3 receptor antagonists for the treatment of affective disorders
US7642281B2 (en) * 2002-08-07 2010-01-05 Helicon Therapeutics, Inc. Indolone compounds useful to treat cognitive impairment
US7220775B2 (en) 2002-08-07 2007-05-22 H. Lundbeck A/S Compound useful for the treatment of neuropathic pain
JP2008517930A (ja) * 2004-10-21 2008-05-29 トランス テック ファーマ，インコーポレイテッド ＧａｌＲ１のアゴニストとしてのビススルホンアミド化合物、組成物、及び使用法
EP2636757B1 (en) * 2008-05-27 2016-11-23 Dako Denmark A/S Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
US20100284977A1 (en) * 2009-04-28 2010-11-11 University Of South Carolina Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
EP2647722B1 (en) * 2010-12-03 2016-07-06 Tsumura & Co. Daikenchuto bioassay method and quality management method using same
WO2013046033A1 (en) 2011-09-30 2013-04-04 Dako Denmark A/S Hybridization compositions and methods using formamide
US11118226B2 (en) 2011-10-21 2021-09-14 Agilent Technologies, Inc. Hybridization compositions and methods
WO2013109713A1 (en) * 2012-01-18 2013-07-25 The General Hospital Corporation Targeting rnas to microvesicles
KR101514440B1 (ko) * 2013-12-13 2015-04-22 고려대학교 산학협력단 갈라닌 수용체 3형의 리간드로서 스펙신의 용도
CN113512592A (zh) * 2021-04-23 2021-10-19 中国科学院深圳先进技术研究院 用于检测甘丙肽分泌细胞的引物、探针以及试剂盒
EP4626454A1 (en) * 2022-11-29 2025-10-08 Neuracle Science Co., Ltd. Use of galr2 agonists to treat gastrointestinal and/or endocrine disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462856A (en) 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
WO1992008133A1 (en) 1990-10-29 1992-05-14 Dekalb Plant Genetics Isolation of biological materials using magnetic particles
WO1992012997A1 (en) 1991-01-16 1992-08-06 The General Hospital Corporation Human galanin
WO1992015015A1 (en) 1991-02-25 1992-09-03 Zymogenetic, Inc. Methods for detecting galanin antagonists
CA2105572A1 (en) 1991-03-06 1992-09-07 Helen F. Evans Human galanin, cdna clones encoding human galanin and a method of producing human galanin
SE9101472D0 (sv) 1991-05-15 1991-05-15 Trion Forskning & Utveckling Galanin antagonist
US5576296A (en) 1991-05-15 1996-11-19 Aktiebolaget Astra Galanin antagonist
US5436155A (en) 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5290808A (en) 1992-11-06 1994-03-01 Carter-Wallace, Inc. Method to control the intake of food
FR2716205B1 (fr) 1994-02-17 1996-04-12 Rhone Poulenc Rorer Sa Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
EP0711830A3 (en) 1994-10-13 1997-06-11 Takeda Chemical Industries Ltd Murine and human galanin receptor
US6562862B1 (en) 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
US6410686B1 (en) 1996-06-05 2002-06-25 Bayer Corporation Galanin receptor 2 protein
SE9602822D0 (sv) 1996-07-19 1996-07-19 Astra Pharma Inc New receptor
DE69739760D1 (de) 1996-07-24 2010-03-25 Neurotargets Ltd Verwendung eines Galanin-agonisten in der Herstellung eines Medikaments zur Verbesserung des Gedächtnisses und anderer cognitiver Funktionen
US6329197B2 (en) * 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
WO1999031130A1 (en) 1997-12-17 1999-06-24 Merck & Co., Inc. Galanin receptor galr3 and nucleotides encoding same

Also Published As

Publication number Publication date
AU4812597A (en) 1998-05-05
EP0956291A4 (en) 2002-10-24
US6329197B2 (en) 2001-12-11
US20010009766A1 (en) 2001-07-26
US7022489B2 (en) 2006-04-04
US6287788B1 (en) 2001-09-11
US20030027254A1 (en) 2003-02-06
US6368812B1 (en) 2002-04-09
AU741041B2 (en) 2001-11-22
WO1998015570A1 (en) 1998-04-16
CA2248222A1 (en) 1998-04-16
JP2002514055A (ja) 2002-05-14
DE956291T1 (de) 2001-05-23
US20030082641A1 (en) 2003-05-01
EP0956291A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
ES2133271T3 (es) Receptores para factores de crecimiento de fibroblastos.
ES2123482T3 (es) Receptor de estrogeno.
ES2154354T3 (es) Ligandos tie-2, metodos para obtenerlos y sus usos.
IL142103A0 (en) Receptor based antagonists and methods of making and using
ES2092976T1 (es) Metodo para la modificacion de los habitos alimenticios.
WO2001098351A3 (en) G-protein coupled receptors
IL142153A0 (en) Non-endogenous, constitutively activated human g protein-coupled receptors
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
WO2000039279A3 (en) Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
ES2112238T1 (es) Acido nucleico.
AU6982500A (en) Fv antibody construct comprising binding sites for a cd16 receptor and a cd30 surface protein
ES2085246T1 (es) Adn que codifica un receptor humano 5-ht1e y utilizaciones del mismo.
WO2001057085A3 (en) G-protein coupled receptors
WO2001087937A3 (en) G-protein coupled receptors
WO2002010387A3 (en) G-protein coupled receptors
WO2001098323A8 (en) G-protein coupled receptors
WO2000050563A3 (en) G protein-coupled receptor resembling galanin receptors
WO2001072836A3 (en) G-protein coupled receptors
NO20025152D0 (no) EDG8-reseptor, dens fremstilling og anvendelse
WO2001090359A3 (en) G-protein coupled receptors
WO2002026825A3 (en) G-protein coupled receptors
WO2001066742A3 (en) G-protein coupled receptors
GB9416536D0 (en) Orphan receptor
NO20024779L (no) G-protein-koblet reseptor
WO1998059041A3 (en) Disease related nucleotide kinases